Research programme: prenylcysteine carboxyl methyltransferase inhibitors - Pharmacia
Alternative Names: pcCMT inhibitors - Pharmacia; Prenylcysteine carboxyl methyltransferase inhibitors research programme - Pharmacia; Research programme: pcCMT inhibitors - PharmaciaLatest Information Update: 02 Aug 2002
Price :
$50 *
At a glance
- Originator Pharmacia Corporation
- Class
- Mechanism of Action Ras protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 29 Aug 2000 Preclinical development for Cancer in USA (Unknown route)